{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:12:06Z","timestamp":1778598726574,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1002\/jps.10361","type":"journal-article","created":{"date-parts":[[2003,4,21]],"date-time":"2003-04-21T10:25:40Z","timestamp":1050920740000},"page":"957-966","source":"Crossref","is-referenced-by-count":28,"title":["An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria"],"prefix":"10.1016","volume":"92","author":[{"given":"Marisa","family":"Peyre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"Sesardic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans P.","family":"Merkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.10361_bb0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1023\/A:1011950732105","article-title":"Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents","volume":"15","author":"Audran","year":"1998","journal-title":"Pharm Res"},{"key":"10.1002\/jps.10361_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0264-410X(99)00191-7","article-title":"Immunogenicity of single-dose diphtheria vaccines based on PLA\/PLGA microspheres in guinea pigs","volume":"18","author":"Johansen","year":"1999","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0264-410X(94)00046-P","article-title":"A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide","volume":"13","author":"Men","year":"1995","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0025","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/IAI.65.5.1716-1721.1997","article-title":"Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine","volume":"65","author":"Singh","year":"1997","journal-title":"Infect Immun"},{"key":"10.1002\/jps.10361_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0264-410X(97)80912-7","article-title":"Controlled release microparticles as a single dose diphtheria toxoid vaccine: Immunogenicity in small animal models","volume":"16","author":"Singh","year":"1998","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0264-410X(00)00343-1","article-title":"Towards clincial testing of a single-administration tetanus vaccine based PLA\/PLGA microspheres","volume":"19","author":"Johansen","year":"2000","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-7799(00)01437-2","article-title":"Ambiguities in pre-clinical assessment of microparticulate vaccines","volume":"18","author":"Johansen","year":"2000","journal-title":"Trends Biotechnol"},{"key":"10.1002\/jps.10361_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0169-409X(97)00053-7","article-title":"New advances in microsphere-based single-dose vaccines","volume":"28","author":"Hanes","year":"1997","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.10361_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLGA microsphere-based vaccines: An analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.10361_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0169-409X(98)00012-X","article-title":"Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines","volume":"32","author":"O'Hagan","year":"1998","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.10361_bb0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1023\/A:1020354809581","article-title":"On technological and immunological benefits of multivalent single-injection microsphere vaccine","volume":"19","author":"Boehm","year":"2002","journal-title":"Pharm Res"},{"key":"10.1002\/jps.10361_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/biol.1999.0205","article-title":"No-pertussis components of combination vaccines: Problems with potency testing","volume":"2","author":"Sesardic","year":"1999","journal-title":"Biologicals"},{"key":"10.1002\/jps.10361_bb0070","first-page":"277","article-title":"Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use","volume":"101","author":"Winsnes","year":"1999","journal-title":"Dev Biol Stand"},{"key":"10.1002\/jps.10361_bb0075","first-page":"16","article-title":"A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation","volume":"42","author":"Thomasin","year":"1996","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.10361_bb0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1023\/A:1011998615267","article-title":"Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives","volume":"15","author":"Johansen","year":"1998","journal-title":"Pharm Res"},{"key":"10.1002\/jps.10361_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0939-6411(98)00095-2","article-title":"Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA\/PLGAs","volume":"47","author":"Johansen","year":"1999","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.10361_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/biol.1994.1052","article-title":"Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity","volume":"22","author":"Redhead","year":"1994","journal-title":"Biologicals"},{"key":"10.1002\/jps.10361_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-3659(96)01363-6","article-title":"Tetanus toxoid and synthetic malaria antigen containing poly(lactide)\/poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response","volume":"41","author":"Thomasin","year":"1996","journal-title":"J Controlled Release"},{"key":"10.1002\/jps.10361_bb0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jbm.820221002","article-title":"Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid\/glycolic acid homo- and copolymers","volume":"22","author":"Tabata","year":"1988","journal-title":"J Biomed Mater Res"},{"key":"10.1002\/jps.10361_bb0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0264-410X(00)00266-8","article-title":"Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines","volume":"19","author":"Sasiak","year":"2001","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0110","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0264-410X(99)00313-8","article-title":"Improved immunogenicity of a core-coated tetanus toxoid delivery system","volume":"18","author":"Tobio","year":"1999","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0167-5699(98)01415-7","article-title":"The generation and maintenance of memory T and B cells","volume":"20","author":"Dutton","year":"1999","journal-title":"Immunol Today"},{"key":"10.1002\/jps.10361_bb0120","series-title":"Antigen delivery systems","first-page":"1","article-title":"The development of controlled release vaccines\u2014The role of the World Health Organisation","author":"Howard","year":"1997"},{"key":"10.1002\/jps.10361_bb0125","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0264-410X(97)00116-3","article-title":"Chronic local tissue reactions, long term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers","volume":"15","author":"Gupta","year":"1997","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0130","series-title":"Microparticulate systems for the delivery of proteins and vaccines","first-page":"1","article-title":"Stability of protein and their delivery from biodegradable polymer microspheres","author":"Schwendeman","year":"1996"},{"key":"10.1002\/jps.10361_bb0135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0264-410X(96)00145-4","article-title":"Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen","volume":"14","author":"Kersten","year":"1996","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0140","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/S0264-410X(01)00230-4","article-title":"Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigen","volume":"19","author":"Scheifele","year":"2001","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002620050499","article-title":"Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres","volume":"47","author":"Ma","year":"1998","journal-title":"Cancer Immunol Immunother"},{"key":"10.1002\/jps.10361_bb0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0264-410X(98)00321-1","article-title":"MHC class I- and class II-restricted processing and presentation of microencapsulated antigens","volume":"17","author":"Men","year":"1999","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0155","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0264-410X(97)00047-9","article-title":"Induction of a cytotoxic T lymphocyte response by immunization with a Malaria specific CTL peptide entrapped in biodegradable polymer microspheres","volume":"15","author":"Men","year":"1997","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0160","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0264-410X(95)00184-3","article-title":"Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells","volume":"13","author":"Moore","year":"1995","journal-title":"Vaccine"},{"key":"10.1002\/jps.10361_bb0165","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/js980070s","article-title":"Delivery of MUC1 mucin peptide by poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses","volume":"87","author":"Newman","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.10361_bb0170","series-title":"Antigen delivery systems","first-page":"227","article-title":"Pre-clinical evaluation and quality control aspects of microparticulate antigen delivery systems","author":"Sesardic","year":"1997"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916312345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916312345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T14:45:47Z","timestamp":1584542747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916312345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["S0022354916312345"],"URL":"https:\/\/doi.org\/10.1002\/jps.10361","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}